Delaware
|
000-54495
|
27-3440894
|
||
(State or jurisdiction
|
(Commission File
|
(IRS Employer
|
||
of incorporation or
|
Number)
|
Identification No.)
|
||
organization)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
(a) | Resignation of Director |
On September 25, 2013, Nickolay Kukekov resigned from his position as a member of the board of directors (the “Board”) of AntriaBio, Inc. (the “Company”). Mr. Kukekov’s resignation was not the result of any disagreements with the Company on any matters relating to the Company’s operations, policies or practices. The Company would like to thank Mr. Kukekov for his dedicated service. |
|
ANTRIABIO, INC.
|
|
|
|
|
|
|
|
DATE: September 30, 2013
|
By:
|
/s/ Nevan Elam
|
Nevan Elam
Chief Executive Officer
|
||
|